← FDA DRUG APPROVALS

FDA ANDA · ANDA091276

INDOMETHACIN

Sponsor: GLENMARK PHARMS LTD

APPLICATION
ANDA091276
TYPE
ANDA
ORIGINAL APPROVAL
2010-12-22
LATEST ACTION
2024-11-21
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

INDOMETHACINPrescription
INDOMETHACIN 50MG · CAPSULE · ORAL
INDOMETHACINPrescription
INDOMETHACIN 25MG · CAPSULE · ORAL

Approval history

2024-11-21Labeling · Supplement 10 · standardAP
2021-04-28Labeling · Supplement 6 · standardAP
2020-02-02Labeling · Supplement 3 · standardAP
2020-02-02Labeling · Supplement 4 · standardAP
2016-05-09Labeling · Supplement 2 · standardAP
2010-12-22OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →